PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CD4 112,219 Target Drug Atovaquone (Mepron)- FDA 11 1 0.00 -0.95 0.09 0.58
CD4 112,219 Target Target CCL5 2,002 199 0.01 -0.95 0.10 0.63
CD4 112,219 Target Target Sphingosine 1-Phosphate Receptor 1 150 15 0.00 -0.95 0.10 0.60
CD4 112,219 Target Target Eotaxin-2/CCL24 19 2 0.00 -0.95 0.11 0.59
CD4 112,219 Target Target CXCL10 2,386 283 0.02 -0.94 0.12 0.64
CD4 112,219 Target Target CXCL11 526 63 0.01 -0.94 0.12 0.62
CD4 112,219 Target Target CCL1 220 30 0.01 -0.93 0.14 0.61
CD4 112,219 Target Target CD14 9,941 1,398 0.04 -0.92 0.14 0.68
CD4 112,219 Target Target CD31/PECAM1 7 1 0.00 -0.93 0.14 0.59
CD4 112,219 Target Target CRG-2 41 6 0.00 -0.92 0.15 0.60
CD4 112,219 Target Target Exodus-2 27 4 0.00 -0.92 0.15 0.60
CD4 112,219 Target Disease Transplant Bone Marrow 26 4 0.00 -0.92 0.15 0.60
CD4 112,219 Target Target CCL21 808 126 0.01 -0.92 0.16 0.63
CD4 112,219 Target Target CXCL9 1,016 159 0.01 -0.92 0.16 0.64
CD4 112,219 Target Target Tegument Protein Vp16 19 3 0.00 -0.92 0.16 0.60
CD4 112,219 Target Drug Acyclovir (Zovirax)- FDA 50 8 0.00 -0.92 0.16 0.60
CD4 112,219 Target Target CD95 4,266 691 0.03 -0.91 0.16 0.66
CD4 112,219 Target Target CD72 198 35 0.01 -0.91 0.18 0.62
CD4 112,219 Target Drug Abacavir 1,496 276 0.02 -0.90 0.18 0.65
CD4 112,219 Target Target CD137 474 120 0.02 -0.86 0.25 0.64
CD4 112,219 Target Target 4-1BB Ligand 135 36 0.01 -0.86 0.27 0.63
CD4 112,219 Target Disease Infection 766,637 30,996 0.11 -0.83 0.28 0.68
CD4 112,219 Target Target CD154 1,512 477 0.04 -0.83 0.32 0.67
CD4 112,219 Target Drug Acyclovir for Injection (Zovirax Injection)- FDA 3 1 0.00 -0.82 0.33 0.60
CD4 112,219 Target Target Exodus-3 8 3 0.00 -0.79 0.38 0.61
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
CD4 112,219 Target Target Ck-beta-11 4 2 0.00 -0.71 0.50 0.61
CD4 112,219 Target Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.00 -0.71 0.50 0.60
CD4 112,219 Target Target CD254 9 5 0.00 -0.67 0.56 0.62
CD4 112,219 Target Target CCL27/CTACK 5 4 0.01 -0.45 0.80 0.62
CD4 112,219 Target Target CTLA-4/Fc 4 4 0.01 -0.45 1.00 0.62
CD4 112,219 Target Disease Infection Upper Respiratory Tract 1 1 0.00 -0.71 1.00 0.61
Collagen 138,882 Target Disease Anxiety Disorder 8,985 1 0.00 -1.00 0.00 0.44
Collagen 138,882 Target Disease Autism 20,962 4 0.00 -1.00 0.00 0.45
Collagen 138,882 Target Disease HIV/AIDS 20,397 5 0.00 -1.00 0.00 0.45
Collagen 138,882 Target Disease Genital Herpes 2,660 1 0.00 -1.00 0.00 0.47
Collagen 138,882 Target Disease Panic Disorder 7,455 3 0.00 -1.00 0.00 0.47
Collagen 138,882 Target Disease Testicular Cancer 4,459 2 0.00 -1.00 0.00 0.47
Collagen 138,882 Target Disease Disabilities 28,757 16 0.00 -1.00 0.00 0.47
Collagen 138,882 Target Disease Genital Warts 1,791 1 0.00 -1.00 0.00 0.48
Collagen 138,882 Target Disease Bipolar Affective Disorder 1,690 1 0.00 -1.00 0.00 0.48
Collagen 138,882 Target Target D(2) Dopamine Receptor 1,559 1 0.00 -1.00 0.00 0.48
Collagen 138,882 Target Disease Seizures 66,465 52 0.00 -1.00 0.00 0.48
Collagen 138,882 Target Disease Dementia 66,782 56 0.00 -1.00 0.00 0.48
Collagen 138,882 Target Disease Onychomycosis 2,201 2 0.00 -1.00 0.00 0.49
Collagen 138,882 Target Disease Malaria 56,215 55 0.00 -1.00 0.00 0.49
Collagen 138,882 Target Disease Tinea Pedis 938 1 0.00 -1.00 0.00 0.49
Collagen 138,882 Target Disease Contraception 21,402 23 0.00 -1.00 0.00 0.49
Collagen 138,882 Target Disease Cardiac Arrest 20,700 23 0.00 -1.00 0.00 0.49
Collagen 138,882 Target Disease Vertigo 10,084 12 0.00 -1.00 0.00 0.50